StonvexLoading…
StonvexStonvexStonvexCore line items from UVE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $393.56M | $1.60B | $400.98M | $400.14M |
Operating Income | $71.69M | $243.07M | $154.62M | $101.84M |
Net Income | $54.29M | $182.95M | $39.83M | $35.09M |
EPS (Diluted) | $1.88 | $6.32 | $1.38 | $1.21 |
Total Assets | $2.77B | $2.84B | $3.09B | $3.28B |
Total Liabilities | $2.18B | $2.29B | $2.59B | $2.82B |
Cash & Equivalents | $595.77M | $408.87M | $405.11M | $367.11M |
Free Cash Flow OCF − CapEx | $153.24M | $377.06M | $352.05M | $290.79M |
Shares Outstanding | 27.91M | 28.01M | 28.05M | 27.93M |